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Raquel Martı́nez6, Noelia Cubero7, Txomin Zabala8, Rosa Cordovilla9, Javier FlandesID
10,
Carlos Disdier11, Alfons Torrego1,2, in collaboration with MULTICRIO Group researchers¶
1 Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2 Biomedical Research
Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain, 3 Respiratory Medicine, Hospital Universitario Álvaro
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In recent years, transbronchial cryobiopsy (TBCB) has come to be increasingly used in inter-
ventional pulmonology units as it obtains larger and better-quality samples than conven-
tional transbronchial lung biopsy (TBLB) with forceps. No multicenter studies have been
performed, however, that analyse and compare TBCB and TBLB safety and yield according
to the interstitial lung disease (ILD) classification.
Objectives
We compared the diagnostic yield and safety of TBCB with cryoprobe sampling versus con-
ventional TBLB forceps sampling in the same patient.
Method
Prospective multicenter clinical study of patients with ILD indicated for lung biopsy. Airway
management with orotracheal tube, laryngeal mask and rigid bronchoscope was according
to the protocol of each centre. All procedures were performed using fluoroscopy and an
occlusion balloon. TBLB was followed by TBCB. Complications were recorded after both
TBLB and TBCB.
Results
Included were 124 patients from 10 hospitals. Airway management was orotracheal intuba-
tion in 74% of cases. Diagnostic yield according to multidisciplinary committee results for
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Pérez-Pallarés J, Martı́nez R, Cubero N, et al.
(2020) Transbronchial biopsy results according to
diffuse interstitial lung disease classification.
Cryobiopsy versus forceps: MULTICRIO study.
PLoS ONE 15(9): e0239114. https://doi.org/
10.1371/journal.pone.0239114
Editor: Minghua Wu, University of Texas McGowan
Medical School at Houston, UNITED STATES
Received: February 17, 2020
Accepted: August 31, 2020
Published: September 21, 2020
Copyright: © 2020 Pajares et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: Project funded by the Spanish Society of
Pulmonology and Thoracic Surgery (SEPAR 2014
research grant) and included in SEPAR’s Integrated
Research Projects for Interventional Pulmonology
(PII SEPAR Interventional Pulmonology).
Competing interests: The authors have declared
that no competing interests exist.
TBCB was 47.6% and for TBLB was 19.4% (p<0.0001). Diagnostic yield was higher for
TBCB compared to TBLB for two groups: idiopathic interstitial pneumonias (IIPs) and ILD of
known cause or association (OR 2.5; 95% CI: 1.4–4.2 and OR 5.8; 95% CI: 2.3–14.3,
respectively). Grade 3 (moderate) bleeding after TBCB occurred in 6.5% of patients com-
pared to 0.8% after conventional TBLB.
Conclusions
Diagnostic yield for TBCB was higher than for TBLB, especially for two disease groups: IIPs
and ILD of known cause or association. The increased risk of bleeding associated with





Transbronchial cryobiopsy (TBCB), which uses modified cryotherapy probes, resulted from
the need to improve the diagnostic yield of conventional transbronchial lung biopsy (TBLB).
Flexible cryotherapy probes as currently used, with greater freezing power and speed than
rigid probes, allow for increased traction on the tissue, which results in larger specimens. Stud-
ies that have analysed histological material obtained by cryoprobe for endobronchial tumours
have observed that, since samples are both larger than those obtained using a conventional
biopsy and histologically better preserved, they facilitate histological diagnosis and the applica-
tion of immunohistochemical techniques [1, 2]. Those observations have led to increased use
of the cryoprobe as an alternative to the conventional biopsy technique for the purpose of
studying diffuse lung diseases [3–6].
However, there are important methodological differences in the mainly retrospective sin-
gle-centre studies of TBCB to date, in terms of both technical and experimental design. Diag-
nostic yields, while superior to those of conventional TBLB, vary between 50.6% and 100%
depending on the study [7]. To date, only one randomized clinical trial (conducted in a single
centre) has compared TBCB and TBLB and analysed the complications associated with each
[6], while no prospective multicenter study has assessed diagnostic yield according to diffuse
interstitial lung disease (ILD) classes or has assessed the risk-benefit profile of both techniques
performed in turn in the same patient.
This study was designed to determine, for the same patient with clinical and radiographic
findings of ILD, the diagnostic yield and safety of TBCB in comparison with TBLB using a




Prospective multicenter study undertaken in 10 interventional pulmonology units between
April 2014 and June 2017. Patients with ILD but no definitive diagnosis referred for lung
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biopsy were included. This indication was performed independently of the purpose of the
study by an expert ILD physician based on clinical and radiological findings (HRCT, high-res-
olution computed tomography). Based on current guidelines, a lung biopsy was requested to
establish a definitive diagnosis. All included patients signed an informed consent prior to their
inclusion in the study.
Population
Inclusion criteria were patients aged 18–80 years, a HRCT pattern indeterminate or alternative
for UIP and absence of definitive diagnosis. Exclusion criteria were definite or probable UIP
pattern in the HRCT scan, use of anticoagulation therapy, presence of a coagulation disorder
(thrombocytopenia <50000 cells/mm3, abnormal platelet count >1 million cells/mm3, inter-
national normalized ratio (INR) >1.5, and activated partial thromboplastin time >50 s), and
unstable heart disease (uncontrolled cardiac arrhythmia or active myocardial ischaemia).
Other exclusion criteria were hypoxaemia (partial pressure of oxygen in arterial blood < 60
mmHg), severe respiratory impairment (forced expiratory volume in 1 s (FEV1)< 50%, total
lung capacity (TLC) < 50%, diffusing capacity of carbon monoxide (DLCO) < 40% of refer-
ence), and unstable heart disease (uncontrolled cardiac arrhythmia, active myocardial
ischaemia).
Data available for the patients included complete blood count, serum biochemistry and
coagulation tests, lung function including forced expiratory volume in 1 s (FEV1), total lung
capacity (TLC) and diffusing capacity of carbon monoxide (DLCO), and thoracic high-resolu-
tion computed tomography (HRCT). Echocardiography was performed as necessary.
Protocol
Patients scheduled for the intervention–TBLB followed by TBCB in that order–in the pulmo-
nology units of the participating hospitals were sedated and monitored by the anaesthesiologist
attached to each unit. Airway management–with laryngeal mask, orotracheal tube or rigid
bronchoscope–was that reflected in the protocol of each centre. All biopsies were fluoroscopy-
guided to zones preselected in accordance with radiological involvement. An occlusion bal-
loon was placed before performing biopsies and the conventional forceps or cryoprobe was
positioned 1–2 cm from the visceral pleura.
The goal was to obtain a minimum of three conventional TBLBs, followed–provided there
were no complications that contraindicated additional biopsies–by a minimum of three
TBCBs. Bleeding was recorded according to the following classification: grade 0 (no bleeding,
i.e., no observed blood remains; grade 1 (mild bleeding, i.e., some observed blood remains but
endoscopic intervention not necessary); grade 2 (slight bleeding, i.e., bleeding requires balloon
occlusion and stops in<3 minutes; grade 3 (moderate bleeding, i.e., bleeding requires balloon
occlusion, needs>3 minutes to bring under control and requires suspension of the procedure;
and grade 4 (severe bleeding, i.e., bleeding is endoscopically uncontrollable, causes haemody-
namic or respiratory instability and requires suspension of the procedure and/or other invasive
haemostatic interventions). Pneumothorax occurrence was assessed by means of fluoroscopy
after the biopsies obtained using each method. Biopsies were performed in several bronchial
segments and lobes of the lung that had previously been identified as affected by thoracic
HRCT. All bleeding and pneumothorax complications were recorded.
Recorded for all patients, prior to commencing the intervention, were blood pressure, heart
and respiratory rates, oxyhaemoglobin saturation and electrocardiogram and capnography
data. All samples were harvested using a flexible videobronchoscope in procedures that
included endoscopic exploration and other diagnostic tests as required.
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Conventional TBLB was performed using a 2-mm biopsy forceps (Biopsy Forceps Boston
1 Ref: 1556, Olympus1 Ref: FB-19E, Biopsy Forceps Medi-Inn Ref BP-40144). The TBCB
was performed using a 900-mm long flexible cryoprobe with diameter 2.4 mm (Ref: 20426–
032) connected to a cryotherapy unit (Erbokryo1 CA). Freezing was applied for 3–4 seconds
after which the bronchoscope was withdrawn. Once intervention was complete, the patient
remained under observation and was discharged if no complications were evident.
Sample processing
Extracted biopsy specimens were fixed in 4% paraformaldehyde and embedded in paraffin; 4-
μm sections were processed for the staining protocol (hematoxylin and eosin, Masson’s tri-
chrome to identify collagen and Orcein stain to detect elastic fibre). Histological analyses were
performed by the pathologists attached to each centre.
Histological assessment
After transbronchial biopsy, the pathologist received clinical and radiological information
about the case. Both, TBLB and TBCB, were evaluated simultaneously. The pathologists classi-
fied the samples according to certainty of diagnosis, as follows: diagnostic pattern, if the sample
contained histologic findings characteristic of a particular form of ILD or if there were nonspe-
cific findings consistent with clinical and radiologic findings suggestive of a disease; or non-
diagnostic pattern, when the findings did not suggest any particular disease or when the
material harvested was less than 1 mm in diameter.
Tissue quality variables were recorded according to an objective protocol and agreement
regarding each individual pathologist’s identification of the histological pattern [8].
Multidisciplinary diagnosis
Finally, all cases were discussed at the Multidisciplinary Meeting (MDM) of each center. First,
clinical and radiological findings were presented. Subsequently the histology was added. The
MDM evaluated each technique sample and how it contributed to the diagnosis. We catego-
rized a biopsy as diagnostic only in those cases were the TBCB or TBLB findings were able to
contributed to a definitive or high confidence diagnosis.
After MDM, the final diagnostics established with conventional TBLB and TBCB were clas-
sified according to Spanish guidelines [9] and the ATS/ERS/JRS/ALAT International Multidis-
ciplinary Consensus Classification [10, 11]. Four disease groups were established–labelled
groups 1, 2, 3 and 4, respectively–as follows: idiopathic interstitial pneumonias (IIPs); ILD of
known cause or association; granulomatous ILD and miscellaneous ILD; and other diagnoses
(non-ILD).
Statistical analysis
Data were analysed using the SPSS statistical package, version 25 for Windows (SPSS Inc, Chi-
cago IL, USA). Results are reported as means and standard deviations for the quantitative vari-
ables and as absolute values and percentages for the qualitative variables. The student-t test
was used to compare the two biopsy techniques. For the categorical variables, a logistic regres-
sion was performed to estimate odds ratio (OR) values along with their 95% confidence inter-
val (CI) and a statistical significance level of 0.05.
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Ethics statement
The study was conducted in compliance with the Declaration of Helsinki and was evaluated
and approved by the clinical research ethics committee (CEIC) of each hospital (CEIC refer-
ence: IIBSP-CRI-2014-05). The study was registered at ClinicalTrials.gov (NCT02464592).
Results
A total of 124 patients were included (Table 1). A pre-intervention echocardiogram was not
available for 38% of the patients; in 24% of the remaining patients, ultrasound abnormalities
were observed. In 2.9% of the cases, mild to moderate pulmonary arterial hypertension (mean
25-55mmHg) was recorded.
With respect to airway management, orotracheal intubation was performed in 74% of the
patients. The time required for biopsies was 15.2±8.1 minutes for TBCB compared to 12.1±8.4
minutes for conventional TBLB (p<0.001). Biopsy zones were selected according to radiologi-
cal involvement. Only 8% of TBCB and TBLB biopsies were performed in the upper lobes.
Diagnostic yield
A total of 942 lung biopsy specimens were evaluated, 508 TBLB and 434 TBCB. The mean
number of biopsies per patient for TBCB was lower than for TBLB (3.5 vs 4.1; p<0.001).
To evaluate diagnostic yield, diagnostic and non-diagnostic patterns were classified sepa-
rately. The diagnostic yield according to histopathology results was higher for TBCB than for
TBLB (54.8% vs. 19.4%; p<0.0001), with TBCB proving to be five times more diagnostically
effective than TBLB (OR 5.1; 95% CI: 3.2–7.9; p<0.0001). Likewise, according to the MDT, the
diagnostic yield was four times higher for TBCB than for TBLB (47.6% vs. 19.4%; OR 3.8; 95%
CI: 2.5–5.8; p<0.0001) (Table 2). Fig 1 show diagnoses with each biopsy method and non diag-
noses. As for multidisciplinary committee diagnoses by disease groups, for groups 1 and 2, the
diagnostic yield for TBCB was higher than for TBLB: in group 1, 21% of patients were diag-
nosed by TBCB vs 9.7% by TBLB, indicating that TBCB was 2.5 times more diagnostically





FVC (L) 2.2 ±12
FVC (% ref) 79±20
FEV1 (L) 1.7±10
FEV1 (% ref) 80±18
FEV1/FVC (% ref) 80.2±8.7
TLC (% ref) 76.6±18.5
DLCO, % ref 57.7±17.4
INR 0.9±0.3
Platelets (x109/L) 214.1±74
Data are presented as mean ± standard deviation, unless otherwise indicated.
% ref, percentage of the reference value. BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC,
forced vital capacity; TLC, total lung capacity; DLCO, carbon monoxide diffusing capacity; INR, international
normalized ratio.
https://doi.org/10.1371/journal.pone.0239114.t001
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effective than TBLB (OR 2.5; 95% CI: 1.4–4.2; p = 0.0008), and in group 2 the differences were
also greater in favour of TBCB, which was 5 times more diagnostically effective than TBLB
(OR 5.8; 95% CI: 2.3–14.3; p = 0.0002). No significant differences were observed in diagnostic
yield for groups 3 and 4. Tables 3 and 4 show the distributions of pathologies in groups. The
multivariate analysis maintained the diagnostic yield differences for the different airway
managements.
Complications
No bleeding was observed after conventional TBLB in 56.4% of patients compared to 44% of
patients after TBCB (p<0.0001); overall, fewer bleeding episodes (all grades) were observed for
Table 2. Multidisciplinary Meeting (MDM) diagnoses by biopsy technique.
MDM diagnostic Conventional forceps N = 124 Cryoprobe N = 124
Idiopathic pulmonary fibrosis 3 (2.4%) 10 (8.1%)
RB ILD-associated 4 (3.2%) 6 (4.8%)
Non-specific interstitial pneumonia 3 (2.4%) 5 (4.0%)
Organizing pneumonia 1 (0.8%) 4 (3.2%)
Desquamative interstitial pneumonia 1 (0.8%) 1 (0.8%)
Hypersensitivity pneumonitis 3 (2.4%) 13 (10.5%)
Drug-induced pneumonitis 1 (0.8%) 3 (2.4%)
Lipoid pneumonia - 2 (1.6%)
Connective tissue disease-associated ILD - 2 (1.6%)
Sarcoidosis 4 (3.2%) 6 (4.8%)
Pulmonary amyloidosis 1 (0.8%) 1 (0.8%)
Langerhans cell histiocytosis - 1 (0.8%)
Lymphangioleiomyomatosis - 1 (0.8%)
Lung neoplasm 3 (2.4%) 3 (2.4%)
Lymphoproliferative syndrome - 1 (0.8%)
Total diagnoses 100 (80.6%) 65 (52.4%)




OR, odds ratio; CI, confidence interval (upper and lower limits in square brackets); RB, respiratory bronchiolitis; ILD, interstitial lung disease.
https://doi.org/10.1371/journal.pone.0239114.t002
Fig 1. Percentage of diagnoses for each method and percentage of patients not diagnosed by either of the two
biopsy methods.
https://doi.org/10.1371/journal.pone.0239114.g001
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conventional TBLB compared to TBCB. The most frequent bleeding associated with either
technique was grade 1 bleeding, at 29.8% for conventional TBLB vs 42.1% for TBCB. Grade 3
bleeding after TBCB was 6.5% compared to 0.8% after conventional TBLB, while there was just
a single case of grade 4 bleeding (0.8%), resulting from TBCB and requiring intubation and
intensive care; this patient died 40 days after the procedure for reasons attributed to diffuse
ILD progression. The multivariate logistic regression analysis indicated that differences in air-
way management did not modify the bleeding risk (any grade) after TBCB.
Three cases of pneumothorax (2.4% of patients) were associated with TBCB, in two cases
requiring a drainage tube. A single pneumomediastinum that was detected late was associated
with both techniques (Table 5). Upper lobe biopsies did not result in an increase in pneumo-
thorax cases for either of the techniques.
Discussion
Our findings demonstrate that, in patients with suspected diffuse ILD, diagnostic yield is sig-
nificantly higher for TBCB than for conventional TBLB, after both histological evaluation and
multidisciplinary committee evaluation. Regarding the diagnoses, a novel finding was in rela-
tion to the distribution of pathologies according to diffuse ILD classes [11], as TBCB resulted
in higher diagnostic yields for the IIPs and ILD of known cause or association (groups 1 and
2). More specifically, TBCB diagnosed more cases of UIP, non-specific interstitial pneumonia
(NSIP) and hypersensitivity pneumonitis (HP).
Within the group of IIPs, it was necessary to distinguish the UIP pattern, related mainly to
idiopathic pulmonary fibrosis (IPF), given the important prognostic implications and cur-
rently available treatment options [12].
Several authors have questioned the usefulness of conventional TBLB to diagnose certain
interstitial diseases, including UIP [13–15]. The results of our study, which are consistent with
those reported for other series [16–19], would indicate TBCB to be a useful technique for the
Table 3. Diagnostic yield for multidisciplinary committee review of diagnoses by biopsy technique.
Conventional forceps Cryoprobe
N = 124 N = 124
















OR, odds ratio; CI, confidence interval (upper and lower limits in square brackets); IIP, idiopathic interstitial pneumonia; ILD, interstitial lung disease.
https://doi.org/10.1371/journal.pone.0239114.t003
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diagnosis of IIPs, as proposed in the Fleischner Society white paper [20]. Recently, Troy et al.
[21] showed in a prospective, multicenter study (COLDICE) high levels of agreement between
TBLC and surgical lung biopsy for histopathological and multidisciplinary diagnoses. Despite
Table 4. Multidisciplinary committee diagnoses by biopsy technique according to diffuse interstitial classification.
GROUP 1. Idiopathic interstitial pneumonias
Conventional Cryoprobe
N = 12 N = 26
Idiopathic pulmonary fibrosis 3 (2.4%) 10 (8.1%)
RB ILD-associated 4 (3.2%) 6 (4.8%)
Non-specific interstitial pneumonia 3 (2.4%) 5 (4.0%)
Organizing pneumonia 1 (0.8%) 4 (3.2%)
Desquamative interstitial pneumonia 1 (0.8%) 1 (0.8%)
GROUP 2. ILD of known cause or association
Conventional Cryoprobe
N = 4 N = 20
Hypersensitivity pneumonitis 3 (2.4%) 13 (10.5%)
Drug-induced pneumonitis 1 (0.8%) 3 (2.4%)
Lipoid pneumonia 0 2 (1.6%)
Connective tissue disease-associated ILD 0 2 (1.6%)
GROUP 3. Granulomatous ILD and miscellaneous ILD
Conventional Cryoprobe
N = 5 N = 9
Sarcoidosis 4 (3.2%) 6 (4.8%)
Pulmonary amyloidosis 1 (0.8%) 1 (0.8%)
Langerhans cell histiocytosis 0 1 (0.8%)
Lymphangioleiomyomatosis 0 1 (0.8%)
GROUP 4. Other non-ILD diagnoses
Conventional Cryoprobe
N = 3 N = 4
Lung neoplasm 3 (2.4%) 3 (2.4%)
Lymphoproliferative syndrome 0 1 (0.8%)
Data are presented as numbers and percentages. RB, respiratory bronchiolitis, IIP, idiopathic interstitial pneumonia; ILD, interstitial lung disease.
https://doi.org/10.1371/journal.pone.0239114.t004
Table 5. Number of complications according to biopsy technique.
Conventional Cryoprobe P
N = 124 N = 124
No bleeding 70 (56.4%) 44 (35.5%) <0.0001
Bleeding
Grade 1 36 (29.8%) 51 (42.1%)
Grade 2 17 (14.0%) 21 (17.4%)
Grade 3 1 (0.8%) 8 (6.5%)
Grade 4 0 1 (0.8%)
Pneumothorax 0 3 (2.4%)
Pneumomediastinum 1 (0.8%) 1 (0.8%)
Data are presented as numbers and percentages.
https://doi.org/10.1371/journal.pone.0239114.t005
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this, TBCB is still not included in the diagnostic algorithm of the latest ATS/ERS/JRS/ALAT
Guideline for IPF diagnosis [22], while no consensus has been reached regarding a favourable
recommendation for TBCB in IPF diagnosis, especially in centres without experience [22, 23].
In relation to groups 3 (granulomatous ILD and miscellaneous ILD) and 4 (other non-ILD
diagnoses), while diagnostic yield for the two techniques were similar, the multidisciplinary
committee found that TBCB more frequently diagnosed certain histologically complex entities
than did conventional TBLB, specifically, Langerhans cell histiocytosis, lymphangioleiomyo-
matosis and parenchymal involvement associated with a lymphoproliferative syndrome. As for
entities such as sarcoidosis and diseases whose distribution or radiological pattern is such that
histological diagnosis is difficult using conventional TBLB, our findings–while they do not
allow for a categorical recommendation in this regard, given the limited number of cases–
would advise, before indicating TBCB, preliminary comparative risk-benefit evaluations for
the two techniques, as well as thorough radiological evaluation.
Our findings reflect a lower percentage of histological and multidisciplinary diagnoses
obtained by TBCB compared to other studies. One explanation for this lower diagnostic yield
is the wide range of experience with the technique–by both the participating hospitals and the
multidisciplinary committee members. Nonetheless, the prospective and multicenter design of
the study would suggest that the results obtained are transversal and reflect the current health-
care reality. In relation to the determination of committee composition, Castillo et al [24]
recently reviewed criteria regarding standardization of the necessary professional experience.
As for experience, it has been demonstrated that diagnostic yield reflect the TBCB learning
curve [25]. Our results reflect TBCB diagnostic yield variability, documented as between
50.6% and 100% in the recently published expert consensus [7]. Our results are also consistent
with those reported for a single-centre randomized clinical trial [6] and for other published
studies [26–28].
With respect to airway management (Fig 2), orotracheal intubation was the main technique
used in our study, although use of a laryngeal mask or rigid bronchoscope did not affect biopsy
duration, the number of biopsies or the number or severity of complications observed. While
the recommendation of a group of experts is to use orotracheal intubation [7], other authors
have used the laryngeal mask or rigid bronchoscope techniques [29, 30] with no major differ-
ence in complications or limitations.
In relation to safety, complications were bleeding and pneumothorax. More grade 3 bleed-
ing was observed after TBCB, brought under control in all cases by a previously inserted occlu-
sion balloon. One case of grade 4 bleeding associated with TBCB required selective bronchial
intubation, while no deaths associated with bleeding were recorded. These results are similar
to those reported by other authors. A meta-analysis by Johannson et al. [31] point to great het-
erogeneity in describing and classifying bleeding, as the rate of moderate to severe bleeding
was 39%, while the range was 0% to 78%. Sharp et al. [32], reported that three deaths occurred
due to bleeding after TBCB (0.5%). It should be noted, however, that there is an absence of
consensus regarding bleeding definition and quantification and, hence, the highly variable
findings of different studies cannot easily be compared. Since we classified bleeding according
to the endoscopic interventions necessary to bring it control, we suggest that our assessment of
the endoscopic and clinical relevance of bleeding was objective.
Our study has certain limitations. First, the pathologists were not blinded as to sampling
technique. However, they were required to record tissue quality variables according to an
objective, pre-established protocol and agreement regarding individual pathologist’s identifi-
cation of the histological pattern. All cases were discussed at the Multidisciplinary Meeting
(MDM) of each center. The MDM evaluated each technique sample and how it contributed to
the diagnosis. We categorized a biopsy as diagnostic only in those cases were the TBCB or
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TBLB findings were able to contributed to a definitive or high confidence diagnosis. Second,
regarding the detection of pneumothorax, the study design limited this possibility. Fluoros-
copy checks immediately after obtaining biopsies with each method allowed only immediate
and not lagged cases of pneumothorax to be detected. Nonetheless, we only observed one case
of pneumomediastinum, observed two hours after the procedure and associated with both
techniques. Our results reflect a number of cases of pneumothorax after TBCB that is consis-
tent with most published series [7]. This result may reflect the characteristics of the included
patients, as only patients with heterogeneous and not only fibrotic interstitial patterns were
included. As recommended by different authors, all biopsies were fluoroscopy-guided, with
the conventional biopsy forceps and cryoprobe positioned 1–2 cm from the visceral pleura.
Studies describing a higher pneumothorax rate include more patients with interstitial pneu-
mopathies and fibrotic patterns and a greater number of subpleural biopsies (<1 cm) [17, 19].
Finally, the number of biopsies taken is a limitation, but published studies vary as to the num-
ber of samples harvested and the optimal number for diagnosing ILD has not been established
[33]. Consistent with our interpretation of the literature, we stipulated that at least 3
Fig 2. Different airway management approaches to transbronchial biopsy with cryoprobe and placement of the
occlusion balloon. (a) Intubation using a bronchoscope and a flexible endotracheal tube (Bronchoflex 7.5 mm, Rüsch,
Teleflex Medical, Durham, NC, USA). (b) Intubation and occlusion balloon insertion using a rigid bronchoscope. (c)
Intubation and occlusion balloon insertion using a laryngeal mask.
https://doi.org/10.1371/journal.pone.0239114.g002
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transbronchial samples should be taken with each biopsy method and that more would be
taken if patient safety and tolerance allowed. Furthermore, we used fluoroscopy to locate and
sample in the region identified by HRCT to be most involved and samples came from different
segmental bronchi.
In conclusion, our multicenter study findings confirm that for ILD diagnoses, compared to
conventional TBLB the information provided by TBCB in a multidisciplinary setting increases
the diagnostic yield for histologically complex entities. We suggest that TBCB is a safe and use-
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Raquel Martı́nez, Noelia Cubero, Txomin Zabala, Rosa Cordovilla, Javier Flandes, Carlos
Disdier, Alfons Torrego.
Project administration: Virginia Pajares.
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